Interleukin-2 receptor subunit beta
| GO Term | Evidence Code | Reference |
|---|---|---|
| signal transduction | ||
| immunoglobulin mediated immune response | ||
| cytokine-mediated signaling pathway | ||
| cytokine-mediated signaling pathway | ||
| interleukin-15-mediated signaling pathway |
| GO Term | Evidence Code | Reference |
|---|---|---|
| endosome | ||
| cytosol | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| interleukin-2 receptor activity | ||
| interleukin-2 receptor activity | ||
| interleukin-2 receptor activity | ||
| coreceptor activity | ||
| interleukin-2 binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 29 |
|
|
||
| 43 |
|
|
||
| 71 |
|
|
||
| 149 |
|
|||
| 476 |
|
|
| Pathway Name | Organism |
|---|---|
| Interleukin receptor SHC signaling | Homo sapiens |
| Interleukin-15 signaling | Homo sapiens |
| Interleukin-2 signaling | Homo sapiens |
| RAF/MAP kinase cascade | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:2841 | asthma | |
| DOID:9146 | visceral leishmaniasis | |
| DOID:0111997 | immunodeficiency 63 | |
| DOID:437 | myasthenia gravis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026